AstraZeneca | AZN - Gewinn Vor Steuern

Aktienkurs
13,692.00
Täglich Wechseln
-208.00 -1.50%
Monatlich
-6.87%
Jährlich
27.63%
Q2 Prognose
13,721.54




Gewinn Vor Steuern Veränderung Datum
AbbVie USD 2.67B 1.71B 2025-12
Alcon AG USD 264M 19M 2025-12
Almirall EUR 30.32M 22M 2025-12
Amgen USD 3.92B 2.35B 2025-09
argenx SE USD 386.05M 99.15M 2025-09
AstraZeneca USD 2.63B 615M 2025-12
Autolus Therapeutics Ltd USD -91.52M 12.93M 2025-12
Bayer EUR -1.16B 735M 2025-09
Biogen USD -56M 613.3M 2025-12
Bristol-Myers Squibb USD 3.11B 1.34B 2025-09
Eli Lilly USD 7.23B 456M 2025-09
Fresenius EUR 601M 122M 2025-12
Fresenius Medical Care EUR 508.46M 105.89M 2025-12
Galapagos EUR -221.49M 117.07M 2025-09
Genmab DKK 55M 427M 2025-12
Gilead Sciences USD 2.08B 1.56B 2025-12
GlaxoSmithKline GBP 1.23B 1.23B 2025-12
GRIFOLS EUR 190.51M 20.03M 2025-06
Haleon GBP 537.5M 249.5M 2025-06
Hikma Pharmaceutical USD 147.5M 3.5M 2025-06
Lonza CHF 624M 197M 2024-12
Merck EUR 1.29B 458.1M 2025-09
Merck USD 6.74B 22M 2025-09
Novartis USD 4.64B 445M 2025-12
Orion EUR 113.4M 213.6M 2026-03
Pfizer USD 3.33B 290M 2025-09
Philips EUR 275M 62M 2025-09
Recordati EUR 144.95M 25.46M 2025-09
Regeneron Pharmaceuticals USD 1.04B 719.6M 2025-12
Roche Holding CHF 4.79B 3.01B 2025-06
Sanofi EUR -1.16B 5.5B 2025-12
UCB EUR 789M 427M 2025-06